
Opinion|Videos|May 3, 2024
Impact Of Durable Agents on Treatment Burden and Quality of Life in Retinal Diseases
The panel concludes its discussion with thoughts on the profound impact durable treatments have on the quality of life of patients with retinal diseases.
Advertisement
Episodes in this series

Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Metformin use associated with reduced incidence of intermediate AMD
2
MeiraGTx Licenses complement-targeted geographic atrophy program from ZipBio
3
Last year in glaucoma at EnVision Summit 2025
4
Looking back at the 2025 EnVision Summit
5

























